Healthcare provider profile · identity verified

David E Gibson, MD

Family Practice · SILER CITY, NC · NPI 1861505356

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	564	151
Amlodipine Besylate	Amlodipine Besylate	499	133
Omeprazole	Omeprazole	454	118
Losartan Potassium	Losartan Potassium	405	96
Gabapentin	Gabapentin	358	90
Lisinopril	Lisinopril	340	93
Metoprolol Succinate	Metoprolol Succinate	327	82
Tamsulosin Hcl	Tamsulosin Hcl	299	78
Levothyroxine Sodium	Levothyroxine Sodium	291	64
Hydrochlorothiazide	Hydrochlorothiazide	275	73
Pravastatin Sodium	Pravastatin Sodium	272	62
Albuterol Sulfate Hfa	Albuterol Sulfate	262	74
Eliquis	Apixaban	246	45
Rosuvastatin Calcium	Rosuvastatin Calcium	231	67
Trazodone Hcl	Trazodone Hcl	204	44
Furosemide	Furosemide	203	63
Metformin Hcl	Metformin Hcl	164	46
Metoprolol Tartrate	Metoprolol Tartrate	164	41
Fluticasone Propionate	Fluticasone Propionate	153	56
Duloxetine Hcl	Duloxetine Hcl	147	45
Donepezil Hcl	Donepezil Hcl	138	26
Pantoprazole Sodium	Pantoprazole Sodium	138	40
Oxycodone Hcl	Oxycodone Hcl	128	26
Metformin Hcl Er	Metformin Hcl	122	38
Glipizide Er	Glipizide	119	31
Allopurinol	Allopurinol	109	29
Mirtazapine	Mirtazapine	106	27
Enalapril Maleate	Enalapril Maleate	104	23
Prednisone	Prednisone	104	62
Simvastatin	Simvastatin	104	22
Potassium Chloride	Potassium Chloride	103	28
Alendronate Sodium	Alendronate Sodium	102	26
Atenolol	Atenolol	96	21
Ezetimibe	Ezetimibe	95	22
Spironolactone	Spironolactone	90	25
Finasteride	Finasteride	86	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	84	13
Clopidogrel	Clopidogrel Bisulfate	83	18
Warfarin Sodium	Warfarin Sodium	82	suppressed
Sertraline Hcl	Sertraline Hcl	80	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	15
Carvedilol	Carvedilol	76	23
Cephalexin	Cephalexin	73	35
Ozempic	Semaglutide	72	20
Famotidine	Famotidine	69	19
Escitalopram Oxalate	Escitalopram Oxalate	68	15
Meloxicam	Meloxicam	68	26
Zolpidem Tartrate	Zolpidem Tartrate	68	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	67	19
Doxycycline Hyclate	Doxycycline Hyclate	64	56
Clonazepam	Clonazepam	63	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	13
Tramadol Hcl	Tramadol Hcl	61	17
Rybelsus	Semaglutide	59	12
Montelukast Sodium	Montelukast Sodium	57	14
Citalopram Hbr	Citalopram Hydrobromide	51	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	13
Synthroid	Levothyroxine Sodium	50	suppressed
Sucralfate	Sucralfate	48	19
Alprazolam	Alprazolam	46	suppressed
Chlorthalidone	Chlorthalidone	46	12
Lovastatin	Lovastatin	41	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	12
Xarelto	Rivaroxaban	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	15
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Ipratropium Bromide	Ipratropium Bromide	38	18
Nitroglycerin	Nitroglycerin	37	26
Azelastine Hcl	Azelastine Hcl	36	16
Diazepam	Diazepam	35	suppressed
Naproxen	Naproxen	34	suppressed
Jantoven	Warfarin Sodium	32	suppressed
Amoxicillin	Amoxicillin	31	26
Glimepiride	Glimepiride	31	suppressed
Colchicine	Colchicine	30	17
Klor-Con M20	Potassium Chloride	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Repatha Sureclick	Evolocumab	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Clotrimazole	Clotrimazole	26	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	15
Glipizide	Glipizide	25	suppressed
Jardiance	Empagliflozin	25	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Azithromycin	Azithromycin	23	21
Hydrocortisone	Hydrocortisone	23	15
Nystatin	Nystatin	23	12
Lactulose	Lactulose	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Clonidine	Clonidine	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Fluconazole	Fluconazole	17	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Ramipril	Ramipril	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Trulicity	Dulaglutide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Mupirocin	Mupirocin	14	12
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Humalog Mix 50-50 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Digoxin	Digoxin	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Methimazole	Methimazole	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error